| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.81B | 56.30B | 54.06B | 52.55B | 48.88B | 45.91B |
| Gross Profit | 6.79B | 6.61B | 6.97B | 6.41B | 6.57B | 6.47B |
| EBITDA | 3.97B | 3.60B | 4.32B | 3.84B | 3.92B | 3.45B |
| Net Income | 1.72B | 1.49B | 2.01B | 1.71B | 1.84B | 1.49B |
Balance Sheet | ||||||
| Total Assets | 30.01B | 30.48B | 30.99B | 29.53B | 27.49B | 26.01B |
| Cash, Cash Equivalents and Short-Term Investments | 6.49B | 7.19B | 8.02B | 6.69B | 5.61B | 5.78B |
| Total Debt | 4.45B | 4.41B | 5.20B | 6.54B | 5.61B | 6.08B |
| Total Liabilities | 13.26B | 13.62B | 14.92B | 14.89B | 13.84B | 13.76B |
| Stockholders Equity | 16.75B | 16.87B | 16.07B | 14.65B | 13.66B | 12.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 936.13M | 2.97B | 758.42M | 1.15B | 1.12B |
| Operating Cash Flow | 0.00 | 1.72B | 3.96B | 2.00B | 2.57B | 2.28B |
| Investing Cash Flow | 0.00 | -993.75M | -715.48M | -1.12B | -1.61B | -691.61M |
| Financing Cash Flow | 0.00 | -1.56B | -1.91B | 198.58M | -1.14B | -2.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥30.28B | 17.64 | ― | 2.48% | 3.88% | 0.31% | |
75 Outperform | ¥3.03B | 13.13 | ― | 2.56% | -3.06% | -38.56% | |
72 Outperform | ¥47.48B | 14.37 | ― | 2.63% | 0.30% | -31.28% | |
68 Neutral | ¥90.19B | 20.67 | ― | 2.47% | 1.86% | 1370.48% | |
60 Neutral | ¥5.89B | 15.40 | ― | 4.07% | 6.08% | 38.00% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | ¥7.63B | 27.36 | ― | 1.41% | 18.03% | -11.68% |